Fourrts India Laboratories Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Metffil VG 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Metffil VG 2mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metffil VG 2mg/500mg/0.3mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Metffil VG 2mg/500mg/0.3mg Tablet.
Metffil VG 2mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Metffil VG 2mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Metffil VG 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Metffil VG 2mg/500mg/0.3mg Tablet contains a combination of Glimepiride, Metformin, and Voglibose. This medication is used to manage type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken alongside proper diet and exercise. Glimepiride decreases blood glucose by increasing insulin release from the pancreas, Metformin reduces glucose production in the liver and improves insulin sensitivity, and Voglibose lowers postprandial (after meals) glucose levels.
Common side effects associated with Metffil VG 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Individuals with known allergies to any of the medicine's components or excipients should avoid taking this medication. The use of Metffil VG 2mg/500mg/0.3mg is also avoided in patients with moderate to severe kidney disease and those experiencing inflammatory bowel diseases, colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.
No, combining this medication with alcohol is not recommended as it may lower blood sugar levels and increase the risk of lactic acidosis.
Yes, Metffil VG 2mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely if missed or delayed meals are taken, alcohol consumption occurs, excessive exercise is done, or other antidiabetic medications are used concurrently with this medication. Regular blood sugar monitoring is essential.
Store this medicine in its original packaging, tightly closed. Follow the specific storage instructions on the label or package. Dispose of any unused medication responsibly by ensuring it is not accessible to pets, children, or other people.